Valuation: Enovis Corporation

Market Cap 1.42B 1.23B 1.16B 1.05B 1.98B 136B 2.01B 13.59B 5.31B 68B 5.35B 5.23B 227B P/E 2026 *
184x
P/E 2027 * 25x
Enterprise Value 2.64B 2.29B 2.14B 1.95B 3.67B 252B 3.73B 25.19B 9.85B 126B 9.91B 9.69B 420B EV / Sales 2026 *
1.13x
EV / Sales 2027 * 1.02x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+0.37%
1 week-18.19%
Current month-15.30%
1 month-4.12%
3 months-5.00%
6 months+12.69%
Current year-7.32%
1 week 23.62
Extreme 23.625
26.82
1 month 23.62
Extreme 23.625
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Director

846 0.0015%
3/31/26 Free

Director

770 0.0013%
3/7/26 Tax

Head of Human Resources

28,555 0.0500%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-18.19%-14.12%-56.22% 1.42B
-0.27%+3.02%-7.81%+23.08% 134B
-1.31%-1.35%-18.76%-2.32% 12.59B
+2.54%+9.19%+108.90%+150.88% 10.73B
+0.33%-1.17%-44.27%-67.14% 4.63B
+2.25%+4.63%-27.52%+43.67% 2.69B
-1.44%-3.01%-30.56%-76.00% 1.71B
-0.64%+0.59%-21.92%-12.05% 1.69B
-0.70%+0.62%-32.56%-34.08% 1.67B
Average +0.13%-0.53%-9.85%-3.35% 18.96B
Weighted average by Cap. -0.13%+2.77%-3.24%+24.56%

Financials

2026 *2027 *
Net sales 2.34B 2.03B 1.9B 1.73B 3.26B 223B 3.31B 22.36B 8.74B 112B 8.79B 8.6B 373B 2.46B 2.13B 2B 1.82B 3.42B 234B 3.47B 23.47B 9.17B 117B 9.23B 9.03B 391B
Net income 3.46M 3M 2.81M 2.56M 4.82M 330M 4.89M 33.03M 12.91M 165M 12.99M 12.71M 551M 55.34M 47.95M 44.92M 40.97M 77.03M 5.28B 78.22M 528M 207M 2.64B 208M 203M 8.81B
Net Debt 1.21B 1.05B 986M 899M 1.69B 116B 1.72B 11.6B 4.53B 58.01B 4.56B 4.46B 193B 1.08B 940M 881M 803M 1.51B 103B 1.53B 10.36B 4.05B 51.81B 4.07B 3.98B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-08-12 US$24.69 +0.37% 1,143,330
26-08-11 US$24.60 +1.49% 887,605
26-08-10 US$24.24 -8.91% 1,756,159
26-08-07 US$26.61 +1.14% 2,058,437
26-08-06 US$26.31 -12.82% 3,127,464
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
24.69USD
Average target price
41.25USD
Spread / Average Target
+67.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock